Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
Public ClinicalTrials.gov record NCT02716857. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Egalet® Abuse-deterrent, Extended-release (ADER) Oxycodone Tablet, Egalet-002, in Patients With Moderate-to-Severe Chronic Low Back Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the analgesic efficacy of Egalet-002 twice daily (BID) in patients with moderate-to-severe chronic low back pain
Study identification
- NCT ID
- NCT02716857
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 549 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2016 (Type not available)
- Primary completion
- Aug 2017 (Actual)
- Completion
- Nov 2017 (Actual)
- Last update posted
- Mar 5, 2018
2016 – 2017
United States locations
- U.S. sites
- 74
- U.S. states
- 28
- U.S. cities
- 68
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 207 | Birmingham | Alabama | 35209 | — |
| Site 202 | Mobile | Alabama | 36608 | — |
| Site 253 | Phoenix | Arizona | 85018 | — |
| Site 260 | Phoenix | Arizona | 85018 | — |
| Site 268 | Phoenix | Arizona | 85029 | — |
| Site 282 | Tucson | Arizona | 85704 | — |
| Site 217 | Anaheim | California | 92801 | — |
| Site 280 | Anaheim | California | 92804 | — |
| Site 220 | La Mesa | California | 91942 | — |
| Site 235 | Laguna Hills | California | 92637 | — |
| Site 215 | Long Beach | California | 90806 | — |
| Site 238 | Los Gatos | California | 95032 | — |
| Site 262 | Napa | California | 94558 | — |
| Site 201 | Oakland | California | 94607 | — |
| Site 225 | Sacramento | California | 95831 | — |
| Site 231 | San Diego | California | 92105 | — |
| Site 237 | San Diego | California | 92120 | — |
| Site 221 | Wildomar | California | 92595 | — |
| Site 248 | Boulder | Colorado | 80301 | — |
| Site 228 | Bradenton | Florida | 34205 | — |
| Site 214 | Clearwater | Florida | 33765 | — |
| Site 270 | Gainesville | Florida | 32607 | — |
| Site 269 | Inverness | Florida | 34452 | — |
| Site 227 | Jupiter | Florida | 33458 | — |
| SIte 204 | Lake Worth | Florida | 33462 | — |
| Site 211 | Miami Beach | Florida | 33140 | — |
| Site 229 | Miami Beach | Florida | 33140 | — |
| Site 278 | Plantation | Florida | 33317 | — |
| Site 232 | Port Orange | Florida | 32129 | — |
| Site 264 | Sarasota | Florida | 34232 | — |
| Site 271 | Winter Park | Florida | 32789 | — |
| Site 223 | Atlanta | Georgia | 30309 | — |
| Site 212 | Marietta | Georgia | 30060 | — |
| Site 245 | Boise | Idaho | 83713 | — |
| Site 255 | Chicago | Illinois | 60614 | — |
| Site 222 | Evansville | Indiana | 47714 | — |
| SIte 236 | West Des Moines | Iowa | 50265 | — |
| Site 277 | Overland Park | Kansas | 66210 | — |
| Site 206 | New Orleans | Louisiana | 70115 | — |
| Site 224 | Shreveport | Louisiana | 71105 | — |
| Site 249 | Pikesville | Maryland | 21208 | — |
| Site 226 | Boston | Massachusetts | 02135 | — |
| Site 254 | New Bedford | Massachusetts | 02740 | — |
| Site 210 | Bay City | Michigan | 48706 | — |
| Site 244 | Jackson | Mississippi | 39202 | — |
| Site 234 | Hazelwood | Missouri | 63042 | — |
| Site 265 | Omaha | Nebraska | 68114 | — |
| Site 266 | Princeton | New Jersey | 08540 | — |
| Site 267 | Somerset | New Jersey | 08873 | — |
| Site 252 | Albuquerque | New Mexico | 87102 | — |
| Site 261 | Kew Gardens | New York | 11415 | — |
| Site 243 | New York | New York | 10019 | — |
| Site 233 | Rochester | New York | 14618 | — |
| Site 208 | Williamsville | New York | 14221 | — |
| Site 203 | Charlotte | North Carolina | 28209 | — |
| Site 213 | Winston-Salem | North Carolina | 27103 | — |
| Site 242 | Winston-Salem | North Carolina | 27103 | — |
| Site 276 | Columbus | Ohio | 43210 | — |
| Site 209 | Franklin | Ohio | 45005 | — |
| Site 259 | Kettering | Ohio | 45429 | — |
| Site 240 | Toledo | Ohio | 43623 | — |
| Site 239 | Oklahoma City | Oklahoma | 73119 | — |
| Site 279 | Duncansville | Pennsylvania | 16635 | — |
| Site 256 | Jenkintown | Pennsylvania | 19046 | — |
| Site 258 | Lansdale | Pennsylvania | 19446 | — |
| Site 205 | Charleston | South Carolina | 29406 | — |
| Site 247 | Greenville | South Carolina | 29601 | — |
| Site 251 | Spartanburg | South Carolina | 29303 | — |
| Site 218 | Austin | Texas | 78704 | — |
| Site 263 | Hurst | Texas | 76054 | — |
| Site 219 | Richardson | Texas | 75080 | — |
| Site 275 | San Antonio | Texas | 78207 | — |
| Site 241 | Everett | Washington | 98201 | — |
| Site 257 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02716857, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02716857 live on ClinicalTrials.gov.